- Home
- LGO vs HLVX Comparison
LGO vs HLVX Comparison
Compare LGO & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGO
- HLVX
- Stock Information
- Founded
- LGO 1988
- HLVX 2020
- Country
- LGO Canada
- HLVX United States
- Employees
- LGO N/A
- HLVX N/A
- Industry
- LGO
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- LGO
- HLVX Health Care
- Exchange
- LGO Nasdaq
- HLVX Nasdaq
- Market Cap
- LGO 100.0M
- HLVX 104.3M
- IPO Year
- LGO 2007
- HLVX 2022
- Fundamental
- Price
- LGO $1.74
- HLVX $2.09
- Analyst Decision
- LGO Strong Buy
- HLVX Hold
- Analyst Count
- LGO 1
- HLVX 1
- Target Price
- LGO $3.70
- HLVX $2.00
- AVG Volume (30 Days)
- LGO 153.1K
- HLVX 835.3K
- Earning Date
- LGO 11-11-2025
- HLVX 11-06-2025
- Dividend Yield
- LGO N/A
- HLVX N/A
- EPS Growth
- LGO N/A
- HLVX N/A
- EPS
- LGO N/A
- HLVX N/A
- Revenue
- LGO $108,526,000.00
- HLVX N/A
- Revenue This Year
- LGO N/A
- HLVX N/A
- Revenue Next Year
- LGO $54.96
- HLVX N/A
- P/E Ratio
- LGO N/A
- HLVX N/A
- Revenue Growth
- LGO N/A
- HLVX N/A
- 52 Week Low
- LGO $1.12
- HLVX $1.34
- 52 Week High
- LGO $2.84
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- LGO 73.41
- HLVX 51.28
- Support Level
- LGO $1.32
- HLVX $2.07
- Resistance Level
- LGO $1.56
- HLVX $2.11
- Average True Range (ATR)
- LGO 0.08
- HLVX 0.02
- MACD
- LGO 0.02
- HLVX -0.00
- Stochastic Oscillator
- LGO 91.74
- HLVX 50.00
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.